We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
Cap. Flow
+$418M
Cap. Flow %
0.12%
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 32.82%
2 Financials 13.01%
3 Consumer Discretionary 11.23%
4 Communication Services 9.04%
5 Industrials 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDIT icon
2251
Editas Medicine
EDIT
$399M
$2.09M ﹤0.01%
949,844
+633,230
+200% +$1.04M
ALGT icon
2252
Allegiant Air
ALGT
$2.76B
$2.07M ﹤0.01%
37,754
-282,410
-88% -$14.6M
STKL
2253
DELISTED
SunOpta
STKL
$2.07M ﹤0.01%
356,790
+41,298
+13% +$217K
APOG icon
2254
Apogee Enterprises
APOG
$873M
$2.06M ﹤0.01%
50,853
-4,551
-8% -$188K
SCS
2255
DELISTED
Steelcase
SCS
$2.06M ﹤0.01%
197,787
-10,468
-5% -$108K
COHU icon
2256
Cohu
COHU
$2.02B
$2.06M ﹤0.01%
106,892
-26,675
-20% -$450K
ENLT icon
2257
Enlight Renewable Energy
ENLT
$12.2B
$2.06M ﹤0.01%
90,649
-9,513
-9% -$172K
DEA
2258
Easterly Government Properties
DEA
$1.18B
$2.05M ﹤0.01%
92,126
-190,406
-67% -$4.15M
RMAX icon
2259
RE/MAX Holdings
RMAX
$203M
$2.05M ﹤0.01%
250,011
+89,735
+56% +$697K
HTZ icon
2260
Hertz
HTZ
$572M
$2.03M ﹤0.01%
297,358
-54,881
-16% -$343K
SYRE icon
2261
Spyre Therapeutics
SYRE
$8.67B
$2.02M ﹤0.01%
135,068
-5,061
-4% -$74.9K
DHC
2262
Diversified Healthcare Trust
DHC
$2.25B
$2.01M ﹤0.01%
560,662
-136,618
-20% -$394K
TFSL icon
2263
TFS Financial
TFSL
$5.17B
$2M ﹤0.01%
154,547
-34,406
-18% -$443K
RMR icon
2264
The RMR Group
RMR
$345M
$2M ﹤0.01%
122,232
+74,963
+159% +$1.15M
EBF icon
2265
Ennis
EBF
$552M
$2M ﹤0.01%
110,118
-26,404
-19% -$495K
CVI icon
2266
CVR Energy
CVI
$3.43B
$2M ﹤0.01%
74,330
-16,205
-18% -$357K
REYN icon
2267
Reynolds Consumer Products
REYN
$5.45B
$1.99M ﹤0.01%
93,052
-37,071
-28% -$839K
ATS icon
2268
ATS Corp
ATS
$2.61B
$1.99M ﹤0.01%
62,584
-3,522
-5% -$96.5K
SLDB icon
2269
Solid Biosciences
SLDB
$773M
$1.99M ﹤0.01%
407,844
+364,265
+836% +$1.29M
IBTA icon
2270
Ibotta
IBTA
$637M
$1.98M ﹤0.01%
54,201
-1,253
-2% -$58.5K
BRKL
2271
DELISTED
Brookline Bancorp
BRKL
$1.98M ﹤0.01%
187,737
-46,996
-20% -$488K
TIC
2272
TIC Solutions Inc
TIC
$1.58B
$1.98M ﹤0.01%
+179,390
New +$1.85M
ATXS
2273
DELISTED
Astria Therapeutics
ATXS
$1.98M ﹤0.01%
369,390
+265,873
+257% +$1.29M
BASE
2274
DELISTED
Couchbase
BASE
$1.97M ﹤0.01%
80,982
-10,406
-11% -$189K
GRPN icon
2275
Groupon
GRPN
$1.07B
$1.97M ﹤0.01%
58,848
+11,078
+23% +$283K

Similar funds

Nuveen's Q2 2025 Portfolio in Review

As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
  • Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
  • Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
  • Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
  • Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
  • Nuveen opened 192 new positions and closed 199 in Q2 2025.
  • Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.